<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112757</url>
  </required_header>
  <id_info>
    <org_study_id>ICBE-S-000283</org_study_id>
    <nct_id>NCT05112757</nct_id>
  </id_info>
  <brief_title>Effective Conversion of Individuals at Risk</brief_title>
  <official_title>Effective Conversion of Individuals at Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Electronics Nederland B.V. acting through Philips CTO organization</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanford Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Philips Electronics Nederland B.V. acting through Philips CTO organization</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and&#xD;
      AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these&#xD;
      symptoms (if any) and inform the participants on their possible diagnosis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective is to analyze how many patients at risk of medical conditions will be&#xD;
      converted to a health care professional by a smartphone application. Historical data (number&#xD;
      of patients at risk of OSA and/or AFib that seeked help for their condition in the past year)&#xD;
      from institute will be used as a reference. We will refer to this as the 'baseline conversion&#xD;
      rate', reflecting the natural transition of patients in the general healthcare system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective conversion</measure>
    <time_frame>6 months after consent</time_frame>
    <description>Number of patients that visited the Primary Care Physician</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smartphone app use</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Smartphone application use</intervention_name>
    <description>Use of a smartphone application</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  High risk of OSA and/or AFib, as defined by the risk algorithm developed by Sanford&#xD;
             health&#xD;
&#xD;
          -  18 years or older, with sufficient English language skills&#xD;
&#xD;
          -  Owning a smartphone with a relatively new operating system (iOS v. 14 (Iphone 6S or&#xD;
             higher) or an Android device v.11&lt;)&#xD;
&#xD;
          -  Able to download and handle an app on a smartphone&#xD;
&#xD;
          -  Willing and able to give informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Diagnosed with OSA and/or AFib&#xD;
&#xD;
          -  Diagnosed health issues that are potentially life threatening or causing mental issues&#xD;
             (stroke, Alzheimer's Disease, depression, etc.)&#xD;
&#xD;
          -  Pregnancy/breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim Weysen, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Philips Healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tim Weysen, MSc</last_name>
    <phone>+31610925696</phone>
    <email>tim.weysen@philips.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sandford Health</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Erin Feltman, BSc</last_name>
      <phone>605-333-1000</phone>
      <email>erin.feltman@sanfordhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>AFib</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

